Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-55,393
Closed -$2.3M 272
2023
Q3
$2.3M Sell
55,393
-4,488
-7% -$213K 0.16% 104
2023
Q2
$3.04M Buy
59,881
+24,730
+70% +$999K 0.19% 77
2023
Q1
$1.53M Buy
+35,151
New +$2.25M 0.11% 114
2022
Q1
Sell
-12,859
Closed -$1.12M 172
2021
Q4
$1.12M Sell
12,859
-195
-1% -$16.7K 0.08% 86
2021
Q3
$1.05M Buy
13,054
+52
+0.4% +$3.74K 0.08% 81
2021
Q2
$907K Sell
13,002
-2,345
-15% -$174K 0.07% 103
2021
Q1
$1.1M Buy
15,347
+269
+2% +$17.6K 0.08% 80
2020
Q4
$842K Sell
15,078
-12
-0.1% -$585 0.07% 75
2020
Q3
$577K Sell
15,090
-1,479
-9% -$56.9K 0.06% 89
2020
Q2
$579K Sell
16,569
-1,137
-6% -$39.7K 0.06% 92
2020
Q1
$611K Buy
+17,706
New +$961K 0.07% 72

Other funds holding CMA

Trilogy Capital's CMA Position: Q4 2023 in Review

Trilogy Capital sold out of Comerica (CMA) in Q4 2023, closing a stake of 55,393 shares — an estimated $2.3M sold.

Trilogy Capital first reported a position in CMA in Q1 2020 and held it in 11 quarters. The position peaked at $3.04M in Q2 2023. 556 funds tracked by Wall St. Rank hold CMA as of Q4 2023.

  • Trilogy Capital reported no remaining Comerica position as of Q4 2023 after selling out during the quarter.
  • Trilogy Capital sold 55,393 Comerica shares in Q4 2023, an estimated $2.3M.
  • Trilogy Capital first reported a position in Comerica in Q1 2020 and held it in 11 quarters.
  • Trilogy Capital's Comerica position peaked at $3.04M in Q2 2023.
  • 556 funds tracked by Wall St. Rank held Comerica as of Q4 2023.

Based on Trilogy Capital's 13F filing for Q4 2023, filed 12 Jan 2024.